Canon Inc has acquired Redlen Technologies, the only independent commercial producer of CZT detectors globally other than Kromek. Kromek's Medical Imaging division competes against Redlen in the medical imaging market and this consolidation leaves Kromek as the sole independent producer of CZT detectors worldwide. The read-across valuation for this division alone suggests Kromek is materially undervalued, and we see fair value in excess of 50p.
28 Sep 2021
Cenkos: Kromek Group Plc -- Redlen acquisition leaves Kromek stronger
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: Kromek Group Plc -- Redlen acquisition leaves Kromek stronger
Kromek Group Plc (KMK:LON) | 7.5 0 7.1% | Mkt Cap: 48.1m
- Published:
28 Sep 2021 -
Author:
Cavendish Research -
Pages:
6
Canon Inc has acquired Redlen Technologies, the only independent commercial producer of CZT detectors globally other than Kromek. Kromek's Medical Imaging division competes against Redlen in the medical imaging market and this consolidation leaves Kromek as the sole independent producer of CZT detectors worldwide. The read-across valuation for this division alone suggests Kromek is materially undervalued, and we see fair value in excess of 50p.